Scientific committee

Scientific Committee

Professor Fausto Badellino, MD Chief Division of Surgery Italian National Institute for Cancer Research, Genoa, Italy Professor Badellino graduated in medicine from the University of Turin, Italy. He did his residency in general surgery and oncology at the same University were he taught for several years surgical anatomy, pathology and general surgery. He served as a resident, assistant and instructor in the Department of Surgery of the Medical School for several years and then moved to the Institute of Oncology at the Saint Giovanni Hospital in Turin. He served there for 18 years and then was appointed Chief of the Division of Surgery and Vice Director of the Scientific Committee of the Italian National Institute for Cancer Research in Genoa. Among his many tenures of office one can mention being Secretary and Vice President of the European Society of Surgical Oncology, President of the Italian Society of Surgical Oncology, President of the Italian Group of Immunoscintigraphy and Radioscintigraphy, Member of the Council of the Italian Society of Senology, Member of the Council of the Italian League for the War against Tumors, Chairman of the Detection and Diagnosis Program of the International Union Against Cancer (UICC), Member of the International TNM Committee of the UICC, Chairman of the Italian TNM Committee and several other national and international organizations dealing with neoplastic diseases. He has taken an active part in the fight against smoking being an Honorary Vice President of the Italian Antismoking Commission and he is still active in international campaigns in the fight against cancer. Professor Badellino has been a mentor for many generations of Italian oncological surgeons and his educational activities equal his scientific ones with more than 200 papers in peer-reviewed journals being published. He has served in many editorial committees including that of Oral Oncology and has lectured extensively in many Hospitals, University Departments and other Academic Institutions.

Joseph A. Califano, III, MD Associate Professor, Head and Neck Division, Division of Head and Neck Cancer Research, Department of Otolaryngology-Head and Neck Surgery and Department of Oncology, The Johns Hopkins University, Baltimore, Maryland, USA Dr. Califano graduated in medicine from Harvard Medical School, Boston, Massachusetts. He moved to The Johns Hopkins Hospital, Baltimore, Maryland where he did his residency in General Surgery and Otolaryngology-Head and Neck Surgery. He then continued with a two-year research training in

Scientific Committee

3

Otolaryngology as a NIH Scholar before moving to the Department of Surgery at Memorial SloanKettering Cancer Center in New York for another two-year fellowship in Head and Neck Surgery. He joined the Head and Neck Division of the Department of Otolaryngology Head and Neck Surgery at The Johns Hopkins Hospital in Baltimore in 2000 as an Assistant Professor, and from 2003 to date is an Associate Professor in the same Department. Dr. Califano has an active research activity in molecular genetics in Oral Cancer being a co-investigator to a large NIH/NIDCR research project on Molecular Progression Model for Head and Neck Squamous Cell Carcinoma with Professor David Sidransky MD of the same Institution. He is also the Principal Investigator in an equally large research project on Molecular Anatomy of Mitochondria in Head and Neck Squamous Cell Carcinoma. His educational activities include training of both undergraduate and postgraduate students in The Johns Hopkins Medical School as well as teaching residents and postdoctoral fellows in the Department. He is a member of the Editorial Board of ORL and Oral Oncology and has reviewed papers for many Journals. He is actively involved in many institutional administrative activities and is a member of several professional Societies and Associations. He has received a number of awards including that of the American Academy of Otolaryngology Head and Neck Surgery Resident Research Award. Dr. Califano's published work includes more than 40 papers in peer-reviewed national and international Journals, 9 book chapters and many published abstracts of national and international Congresses. He has participated in many Round Tables and delivered a large number of lectures as an invited speaker in Hospitals, University Departments and Academic Institutions in the USA and abroad.

Gary L. Clayman, DDS, MD, FACS Professor and Director of Head and Neck Cancer Program, Alando J. Ballantyne Distinguished Chair of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas Gary Clayman graduated BS in Biology and DDS from Case Western Reserve University, Cleveland, Ohio. He received his MD from Northeastern Ohio Universities College of Medicine, Rootstown, Ohio, and MS in Immunobiology from the Medical University of Minnesota, Minneapolis, Minnesota. He did his training in general surgery and otolaryngology/oncology head and neck surgery in the University of Minessota, Mineapolis and a research fellowship and fellowship in head and neck surgical oncology at the University of Texas M.D. Anderson Cancer Center Houston, Texas. He has risen all the academic appointments from Clinical Fellow to Professor in the Department of Head and Neck Surgery in the same institution. He is also Professor and Biologist, Department of Cancer Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, Adjunct Professor, Department of Otolaryngology and Communicative Sciences, Baylor College of Medicine, Houston, Texas and Adjunct Professor, Department of Oral Biology and Oral Medicine, The University of Texas-Houston Dental Branch, Houston, Texas. Gary Clayman is also the Director of Research and Deputy Chairman of the Department of Head and Neck Surgery as well as Deputy Head of the Division of Surgery at University of Texas M.D. Anderson Cancer Center Houston Texas. He has an active membership in several Institutional Committees and an active involvement in many Committees of National Societies and Associations including the American Cancer Society, the American Association of Otolaryngology and Head and Neck Surgery, the Society of Head and Neck Surgeons, the National Institute of Dental Research and the American Academy of Otolaryngology. He has received a great number of honors and awards including the Joseph A. Keller Award, the Career Development Award of the American Cancer Society and the Alando J. Ballantyne

4

Scientific Committee

Distinguished Chair in Head and Neck Surgery. He has been extensively involved with research having executed many funded research protocols. He has published extensively in the international literature with 140 papers being published in peer-reviewed journals. He has contributed with chapters in 22 books and serves in 6 editorial and review activity boards, including the Laryngoscope, Head and Neck and Oral Oncology. He has delivered many lectures as an invited speaker and visiting Professor to Congresses, faculty departments, and Universities in the USA and abroad. He has an extensive number of memberships in National and International societies in the USA and abroad.

Peter G. Cordeiro, MD, FACS Chief of the Plastic and Reconstructive Surgery Service, Memorial SloanKettering Cancer Center, Associate Professor of Surgery, Cornell University Medical Center, New York After graduating from Harvard Medical School, Dr. Cordeiro completed a general surgery residency at the Harvard Surgical Service, New England Deaconess Hospital in 1989. He completed his plastic surgery residency at New York University and fellowships in microsurgery at Memorial Sloan-Kettering Cancer Center and craniofacial surgery at the University of Miami Medical School. Dr. Cordeiro is dually board certified in general surgery and plastic surgery. He currently serves as Chief of the Plastic & Reconstructive Surgery Service, Memorial Sloan-Kettering Cancer Center, Director of the Residency Training and Microsurgical Fellowship and is an Associate Professor of Surgery at Cornell University Medical Center. Dr. Cordeiro's main clinical interests are in oncologic reconstructive plastic surgery with a principle focus in head and neck reconstruction and breast reconstruction. He is a member of the Editorial Board of several Journals including the Journal of Reconstructive Microsurgery and the Annals of Surgical Oncology. He has served in many regional and national committees and he is a member of several scientific and medical societies including The Head and Neck Society, the International Society for Reconstructive Microsurgery and the World Society for Reconstructive Microsurgery as a founding member. He has given more than 65 lectures as an invited speaker in many countries around the world. He has contributed extensively to scientific and clinical literature in these areas and has published over 120 articles and book chapters on innovative approaches and algorithms to reconstruction of the mandible, midface, oral cavity, and the breast. ~ ' =

I ] /'

.

~,i' i~,,t? Professor Oslei Paes de Almeida, DDS, MSc, PhD ~

Professor of Oral Pathology, Faculty of Dentistry, University of Campinas, Piracicaba, Sgo Paulo, Brasil Professor Oslei Paes de Almeida qualified in Dentistry from the University of Campinas, Silo Paulo, Brasil. He obtained his MSc and PhD degrees at the Medical School of Ribeirgo Preto, University of Sgo Paulo. After obtaining his PhD degree he was trained for two years in Oral Medicine and Pathology at the University of London. Returning to Brazil he organized with Dr. Lourenco Bozzo the Department of Oral Pathology & Medicine at the University of Campinas. He became Professor and Head of the Department / i

~

|

Scientific Committee

5

in 1990 and from that date he is responsible for the clinical, histopathological and experimental oral pathology and medicine services. He is also Director of post graduate studies and responsible for MSc and PhD courses. He has served as Vice-Dean in the Dental School of Piracicaba for five years. Professor Almeida has published extensively in the scientific literature being the author of more than 170 papers, mainly in international peer-reviewed journals. He contributed with book chapters in several books and has delivered lectures in many Academic Departments, Hospitals and Universities in Brazil and abroad. His main research interests are the infectious diseases of the oral cavity and the diagnosis of oral cancer.

Michael Ehrenfeld, MD, DDS, PhD Professor of Oral and Maxillofacial Surgery, Director, Department of Oral and Maxillofacial Surgery Ludwig-Maximilians-Universit~it, Mfinchen, Germany Professor Ehrenfeld graduated in dentistry and medicine from Johann-Wolfgang-Goethe-University, Frankfurt am Main, Germany. He also did his Doctorate degrees in both medicine and dentistry in the same University. He was trained in Maxillofacial Surgery in Eberhard-Karls-University, Tfibingen, Germany and in 1987 he was appointed Senior Physician at the Department of Maxillofacial Surgery. In 1989 he presented his PhD (habilitation) at the Eberhard-Karls-University, Tfibingen, Germany. From 1990 to 1996 he was Deputy Director of the Department of Oral and Maxillofacial Surgery at the University of Tfibingen. In 1996 he was appointed Professor, Director and Chairman of the Department of Oral and Maxillofacial Surgery at Ludwig-Maximilians-University, Mfinchen. Professor Ehrenfeld apart from his educational activities in teaching undergraduate and postgraduate students of both the Medical and Dental School of Ludwig-Maximilians University, also has a keen scientific interest in clinical research. In 1988 he was awarded the Hans-von-Seemen-Award from the German Association of Plastic and Reconstructive Surgery and 1990 the Martin-Wal3mund-Award from the German Association of Maxillofacial Surgery. In 1999 he was appointed Chairman of the AO European Craniomaxillofacial Education and Steering Committee to which he was re-elected in 2002. Professor Ehrenfeld's fields of activities include microsurgery, treatment of congenital malformations, traumatology, plastic and reconstructive surgery, preprosthetic surgery and dental implantology. He has published more than 60 papers in peer-reviewed medical and dental Journals, has presented a large number of papers in national and international meetings and has delivered lectures as an invited speaker in many Hospitals, Academic Departments and Universities in Germany and abroad.

Arlene A. Forastiere, MD Professor of Oncology, The Johns Hopkins University School of Medicine Professor of Otolaryngology, Head and Neck Surgery, and Radiation Oncology The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Arlene Forastiere graduated in medicine from New York Medical College in Valhalla and did her residency in medicine in Albert Einstein Medical Center in Philadelphia and at the University of Connecticut School

Scientific Committee of Medicine at Farmington. She also did a two year research fellowship in Hematology-Oncology at Memorial Sloan-Kettering Cancer Center New York. After serving as a clinical instructor in medicine at the University of Connecticut School of Medicine and Cornell University Medical College New York, she was a Senior Investigator of the Baltimore Cancer Research Program of the National Cancer Institute and University of Maryland Cancer Center, Baltimore. She was then appointed Assistant Professor in the Department of Internal Medicine and Otolaryngology in the University of Michigan Medical School in Ann Arbor, being promoted to Associate Professor in 1988. The same year she moved to The Johns Hopkins University School of Medicine were she served as Associate Professor of Oncology and Otolaryngology until 1998 when she was promoted to the rank of Professor. In 2003 she was also appointed Professor of Radiation Oncology at the same institution. Arlene Forastiere has an active membership in several Institutional Committees and an active involvement in many Committees of National and International Societies and Associations including the American Society of Clinical Oncology, the American Association for Cancer Research, the American Association of University Woman, the European Society for Medical Oncology and the American Head and Neck Society. She serves in the Editorial Boards of the International Journal of Radiation Oncology, Biology and Physics, Head and Neck, the Cancer Journal, the Journal of Clinical Oncology and Medical Oncology. She is a member of many scientific and advisory committees in the USA and abroad. She has accomplished many funded research protocols, whereas a large number of local and nationally funded research protocols are now being executed. Arlene Forastiere has published extensively in the literature with more than 140 papers and 110 structural abstracts being published in peer-reviewed Journals. She has edited 2 books and contributed with chapters in 49 books.

Susanne M. Gollin, PhD, FFACMG Professor of Human Genetics, Otolaryngology, and Pathology, University of Pittsburgh Graduate School of Public Health and Director, Cytogenetics Facility, Univ. Pittsburgh Cancer Institute Pittsburgh USA Susanne M. Gollin, PhD, is a clinical cytogeneticist, board certified by the American College of Medical Genetics. She is a Professor of Human Genetics, University of Pittsburgh Graduate School of Public Health and Associate Professor of Otolaryngology and Pathology at the University of Pittsburgh School of Medicine: Director of the University of Pittsburgh Cancer Institute (UPCI) Cytogenetics Facility: and Director of Research and Clinical Cytogenetics Consultant in the Pittsburgh Cytogenetics Laboratory. Dr. Gollin completed her undergraduate and graduate training at Northwestern University, where she received a doctorate in Biological Sciences in 1980. She had Postdoctoral Training in Genetics at the University of Rochester School of Medicine and Dentistry and Cell Biology and Genetics at Baylor College of Medicine. Her academic career began in 1984 as an Assistant Professor of Pathology and Pediatrics, University of Arkansas for Medical Sciences and Director of the full service Cytogenetics Laboratory at Arkansas Children's Hospital. In 1987, she was recruited to the University of Pittsburgh Graduate School of Public Health and the University of Pittsburgh Cancer Institute to initiate a research program in cancer cytogenetics and direct the University of Pittsburgh Clinical Cytogenetics Laboratory which was later to merge with two other laboratories to become the Pittsburgh Cytogenetics Laboratory. Dr. Gollin rose through the ranks and in 2003, she was appointed Professor of Human Genetics. She continues her clinical cancer cytogenetics service in the Pittsburgh Cytogenetics Laboratory.

Scientific Committee

7

Throughout her career, Dr. Gollin has focused on the cytogenetic changes underlying diseases including head and neck and oral cancer, childhood and adult brain tumors, leukemia, autoimmune diseases, posttransplant lymphoproliferative disease, as well as other rare tumors and inherited disorders. Much of Dr. Gollin's research is focused on understanding the biology of these disorders with the goals o f improving disease diagnosis and discovering genetic alterations that could serve as biomarkers of diagnosis and prognosis as well as targets for therapy. Over the past six years, she has been investigating the mechanism of chromosomal instability in cancer cells, including the role of the cytoskeleton in chromosomal instability and the process o f gene amplification and their translational implications. She has been awarded federal, state, and foundation grants for research projects concerning genetic alterations in oral cancer and more recently, breast cancer. In addition, she has received federal funding for the purchase of state-of-theart chromosome imaging instrumentation for the UPCI Cytogenetics Facility to enhance and support cytogenetic investigations in the context of a variety of cancer and other biomedical research projects. Dr. Gollin also devotes substantial time to teaching and mentoring graduate students and postdoctoral fellows in her research laboratory in the Department of Human Genetics, training Pathology Residents and Fellows in clinical cytogenetics, at the University of Pittsburgh. Her teaching includes courses on Chromosomes and Human Disease and Genetic Techniques. For the past decade, Dr. Gollin served as a member and them Vice-Chair of the Allegheny County Board of Health. She also served on the Clinical Laboratory Improvement Advisory Committee at the U.S. Centers for Disease Control and Prevention, on study sections for the National Institutes of Health, and has reviewed grant proposals for the Dutch Cancer Society. Dr. Gollin serves as a consultant to the U.S. Food and Drug Administration~ where she is also a member of the Immunology Devices Panel, a Medical Devices Advisory Committee in the Center for Devices and Radiological Health. She is a diplomate of the American Board of Medical Genetics in Clinical Cytogenetics. Her many professional memberships include serving as a founding fellow PhD in the American College of Medical Genetics; a member of the American Society of Human Genetics; a member of the American Association for Cancer Research; a member of the American Society for Cell Biology; and an associate member of the American Head and Neck Society. Dr. Gollin has published more than 75 peer-reviewed articles in various scientific journals, book chapters, and encyclopedia contributions~ and serves as a referee for a number of scientific journals. She has been invited to present lectures about her innovative research on genetic changes in oral and head and neck cancer cells at Universities and conferences in the USA, Europe~ and Japan.

J. Silvio Gutkind, PhD Chief, Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institute of Health~ Bethesda, Maryland, USA Dr. J. Silvio Gutkind is a Senior Investigator in the National institute of Dental and Craniofacial Research, National Institutes of Health (USA), and is the Chief of the Oral and Pharyngeal Cancer Branch. He received his PhD in pharmacy and biochemistry from the University of Buenos Aires, Argentina. He joined the National Cancer institute, USA, in 1988, where he carried out research on the normal and oncogenic function of nonreceptor protein-tyrosine kinases. He subsequently moved to the National institute of Dental and Craniofacial Research, where he established a new program addressing the molecular basis of cancer by studying normal and aberrant functions of molecules involved in the transduction of proliferative signals. His laboratory has made seminal contributions to the fiel& and helped elucidate some o f the basic

s

Scientific Committee

molecular mechanisms whereby cell surface receptors regulate the nuclear expression of growth promoting genes. In 1998, he was appointed as the Chief of the Oral and Pharyngeal Cancer Branch. Dr. Gutkind is a national and international leader in the study of basic mechanisms in malignant cell growth and in head and neck cancer research. His laboratory has addressed the molecular basis of cancer by studying normal and aberrant functions of molecules involved in the transduction of proliferative signals. He has made seminal contributions to the field, and helped elucidate some of the basic molecular mechanisms whereby cell surface receptors regulate the nuclear expression of growth promoting genes. His research team has also pioneered the use of genomic and proteomic approaches to understand head and neck cancer, and has led an international effort aimed at deciphering the nature of the genes expressed in oral malignancies. He has been member of numerous Editorial Boards of scientific journals, including Oral Oncology, Journal of Biological Chemistry, and Biochemistry, and has being the Editor and Co-Editor of three books, "Signaling Networks and Cell Cycle Control", "Head and Neck Cancer, Emerging Perspectives", and "Signal Transduction and Human Disease", which reflects his leadership role in the field. Dr. Gutkind has been the recipient of numerous awards including the National Institute of Dental Research Director's Exemplary Service Award and the National Institutes of Health Merit Award, and the IADR Oral Medicine and Pathology Research Award. He has organized several national and international symposia, and is a highly sought after speaker, having delivered numerous keynote lectures at the most prestigious national and international meetings and conferences. He has published over 200 scientific manuscripts, including many studies in top ranked journals such as Cell, Molecular Cell, Cancer Cell, Science, and Nature, and contributed numerous review articles and book chapters addressing both basic molecular mechanisms and oral cancer research. Dr. Gutkind is a world renowned scientist, and leader in the field of molecular mechanisms in head and neck cancer.

I

RyuichiHayashi,MD

Chief, Department of Head and Neck Surgery, National Cancer Center Hospital East, Chiba, Tokyo, Japan Dr. Hayashi graduated in medicine from Keio University School of Medicine, Tokyo, Japan. He did a residency in Plastic and Reconstructive Surgery at the same University and continued in General Surgery at Osaka National Hospital in Osaka. He finished his training as a Resident in Head and Neck Surgery at the National Cancer Center Hospital in Tokyo. He was then appointed Assistant in Plastic and Reconstructive Surgery in Keio University in Tokyo before joining the Medical Staff at the Department of Head and Neck Surgery at the National Cancer Center Hospital East in Chiba. From 1996 to date is the Chief of the Department of the Head and Neck Surgery at the same institution. Dr. Hayashi is a member of the Japan Society for Head and Neck Cancer, the Japan Society of Clinical Oncology, the Oto-Rhino-Laryngological Society of Japan and the Japan Society of Stomato-Pharyngology. His research interests include microvascular reconstruction of complex oro-pharyngeal defects, combined treatments and molecular biology related to treatment response in head and neck cancer. He has published many papers in national and international peer-reviewed journals and has presented several papers and courses in national and international meetings in Japan and abroad. Dr. Hayashi is an acknowledged authority in the surgical treatment of head and neck cancer and in free tissue transfer techniques in Japan.

Scientific Committee

9

Emmanuel S. Helidonis, MD, FACS Professor of Otorhinolaryngology Medical School, University of Crete, Greece Professor Emmanuel Helidonis graduated MD from the Medical School of Athens University from were he also received his Doctorate Degree. He was resident in Otorhinolaryngology at the Red Cross Hospital in Athens, Greece and then at the Eye and Ear Hospital, Medical School of the University of Pittsburgh, USA. Following his return to Greece he served in several Academic positions as an Associate Professor at the Department of Otolaryngology of the Medical School of Athens University, and as Professor and Chairman in the Medical School of the University of Patras, Greece. During the last 17 years he is Professor and Chairman in the Department of Otorhinolaryngology, University of Crete, Greece. He has also served as Dean of the Medical School of University of Crete. Professor Helidonis is a member of various Scientific Societies including the Greek Society of Otorhinolaryngology, Head and Neck Surgery~ the American Academy of Otorhinolaryngology, Head and Neck Surgery, the American College of Surgeons, the European Rhinologic Society, the Royal Society of Medicine, the American Academy of Otolaryngologic Allergy, the Balkan ORL Society, and the European Society of Otology. He is a founding member of the Cretan Society of Otorhinolaryngology, the Greek Society of Otorhinolaryngologic Allergy and Immunology, the Greek Medical Laser Society, the Greek Society of Phoniatrics and Difficulty in Swallowing, the Balkan ENT Society and the Greek Society of Facial Plastic and Reconstructive Surgery. He is a past President of the Greek Society of Otorhinolaryngology and of the Greek Medical Laser Society. He is a member of the Executive Committee of IFOS, and has been a Visiting Professor at the Departments of Otolaryngology of the University of Pittsburgh and University of Virginia, USA. He has organized a large number of national and international ENT congresses and meetings, and has lectured extensively in numerous Scientific Meetings in Greece and abroad. Professor Helidonis has a strong interest in social and communal activities. He has served as President of the City Council in the capital of Crete, Heraklion, Greece, and as President of the Greek Red Cross, district of Crete. He has published over 250 papers in national and international peer-reviewed Journals, has written books on Otorhinolaryngology~ contributed with chapters in medical books, and has written numerous articles for the Greek press. He has served as member and as president of various institutional and external scientific committees. He has recently been appointed President of the Committee for Cochlear Implants of the Greek Ministry of Health. Professor Helidonis was bestowed with many awards from the Greek Society of Otolaryngology, the Medical School of Crete and the American Academy of Otolaryngology. Among his research interests one can include the development of hyperspectral imaging in otolaryngology (President's Award of the scientific exhibit, American Academy of Otolaryngology), the CO2 Laser thermo-chondroplasty (Maiman awards), the use of Excimer Laser in ENT and the depiction of Otorhinolaryngologic diseases in the Minoic civilization. Professor Helidonis is a leading figure in ENT Clinical Practice, Research and Education in Greece and has developed scientific and cultural ties between Greece and its neighboring ENT national societies.

lO

Scientific Committee

Jean-Claude Horiot, MD, PhD Professor of Radiation Oncology, Universit6 de Dijon-Bourgogne (France) Director. Centre de Lutte contre le Cancer G.E Leclerc, Dijon (France) Jean-Claude Horiot received his Medical degree at the University of Lyon in 1965. He obtained his French Board of Radiology and Radiation Therapy in 1969 and the American Board of Therapeutic Radiology in 1971. He spent about 21 years at the M.D. Anderson Hospital (1970-1972) as a fellow in radiation oncology with Gilbert H. l~letcher and then as Consultant in Radiotherapy. Professor and Head of the Radiotherapy department at the University of Dijon (France) since 1972, he is now the Director of the Cancer Institute G.E Leclerc in Dijon since 1999. His major commitment in clinical research was undertaken in the EORTC in which he was one of the founders and chairmen of the radiotherapy group. He pioneered the development of quality assurance in radiotherapy trials and later became chairman of the Quality Assurance Committee of the EORTC for all disciplines. He was the president of the EORTC (1997-2000) and is now acting as the EORTC chairman of the IDMC (Independent Data Monitoring Committee). He coordinated a number EORTC phase III trials including hyperfractionation and accelerated radiotherapy protocols which resulted in clinical confirmation of the underlying radiobiological concepts. Other research interests include carcinoma of the cervix, rectal cancers, breast cancers and cutaneous lymphomas. He took an active participation in developing and managing several international societies and was President of ESTRO, FECS and ISRO. Jean-Claude Horiot authored over 500 publications in peer-reviewedjournals and about 600 presentations in scientific meetings. He has received several awards including the Veil, Louise Buchanan, Glyn Evans, Breur, Regaud, Aneurin Bevan and Ells Berven lectures, in 1999, he was awarded the "Pezcoller Recognitition for Contribution to Oncology". in 2002, he co-authored the 2na Edition of the Oxford Textbook of Oncology.

Professor Yoichiro Kameyama, DDS, PhD Professor of Pathology, School of Dentistry Aichi-Gakuin University, Japan Dean of Dental Studies, School of Dentistry Aichi-Gakuin University, Japan Professor Kameyama graduated in Dentistry from Tokyo Medical and Dental University in Japan. He did his internship and residency in the Department of Periodontology in the School of Dentistry of University of Alabama, USA. After his return to Japan he worked in the Department of Oral Pathology in the School of Dentistry of Tokyo Medical and Dental University from were he was awarded his PhD degree. From 1969 to 1974 he was Assistant Professor and from 1974 to 1976 Associate Professor in the Department of Anatomy in the Faculty of Medicine of University of Manitoba in Canada. In 1977 he was appointed Associate Professor and in 1979 Professor and Head of the Department of Pathology, School of Dentistry Aichi-Gakuin University, Japan. In 2000 he was appointed Dean of the School of Dentistry. Professor Kameyamas' research interests lie in both periodontal histopathology, tumor pathology and the

Scientific Committee

11

presence of papillomaviruses in oral tumors. He has published extensively in national and international medical and dental journals. He is a member of many international societies including the American Academy of Oral and Maxillofacial Pathology. the International Association of Oral Pathologists and the International Association of Dental Research. He was President of the Japanese Society of Oral Pathology from 1991 to 1997.

Luiz Paulo Kowalski, MD, PhD Director, Department Head and Neck Surgery, Centro de Tratamento e Pesquisa Hospital do Cfincer A.C. Camargo, S~o Paulo, Brazil and Professor of Oncology, Faculty of Medicine, University of S~o Paulo, Brazil Luiz Paulo Kowalski is a graduate of the Medical School of the Universidade Federal do Paranfi~ Brazil. After his residency in Surgical Oncology at the Cancer Hospital of Silo Paulo he undertook a Fellowship in Head and Neck Surgery at Hospital Heli6polis. He obtained his PhD degree in Otorhinolaryngology from the Escola Paulista de Medicina in Silo Paulo. He has also completed a 6-months stay in the Department of Head and Neck Surgery at Memorial Sloan-Kettering Cancer Center in New York. He was awarded the academic title of Professor of Oncology at Universidade de Sgo Paulo in 1996. In 1990 he was appointed as the Director of the Department of Head and Neck Surgery and Otorhinolaryngology in the Hospital do Cfincer A.C. Camargo. His academic appointments include duties as Professor of the Postgraduate Courses of Oncology at University of S~o Paulo (since 1991) and Oncology at Funda¢~o Antonio Prudente (since 1997). He is a member of many professional organizations, including the ICOOC, American Head and Neck Society, Brazilian Head and Neck Surgery Society. He has served as President of the IV Brazilian Oral Cancer Congress~ and President of the 8th International Congress on Oral Cancer. Dr. Kowalski has published more than 230 articles in peer-reviewed national and international journals (130 in international journals), has written 3 Theses, 70 book chapters, and has edited 5 books. His main research interests deal mainly with biomarkers, epidemiology and prognostic factors of oral cancer~ as well as the management of the neck of oral cancer patients. I I

Professor John D Langdon, MB, BS, BDS, MDS, FDSRCS, FRCS, FMedSci, FKC Professor of Oral and Maxillofacial Surgery King's College London Hon. Consultant King's College Hospital NHS Trust and Guy's and St. Thomas' Hospital NHS Trust Director of Modernisation and Health Services Delivery, Guy's, King's and St. Thomas' Dental Institute John D. Langdon graduated in Dentistry and Medicine from the London Hospital Medical College. He is a Fellow in Dental Surgery from the Royal College of Surgeons of England and a Fellow of the Royal College of Surgeons of Edinburgh. He holds an MDS degree from the University of London and he is a Fellow of the Academy of Medical Science and of King's College London.

12

Scientific Committee

He was trained in Oral and Maxillofacial Surgery at the London Hospital Medical College Dental Institute from 1965 until 1976, where he was House Officer, Registrar and Senior Registrar. In 1977 he was a Senior Registrar at King's College Hospital Medical College. He was appointed Consultant Oral and Maxillofacial Surgeon at Queen Mary's Hospital, Roehampton and Ashford Hospital, Middlesex from 1977 until 1983 when he was appointed Senior Lecturer/Consultant in the Department of Oral and Maxillofacial Surgery of King's College School of Medicine and Dentistry. In 1992 he was appointed Professor of Oral and Maxillofacial Surgery King's College School of Medicine and Dentistry of King's College London. Professor Langdon is a joint author of 5 textbooks, 18 chapters in other textbooks and 124 scientific papers in peer-reviewed journals. He holds a great number of Academic Honours including the Down Surgical prize of the British Association of Oral and Maxillofacial Surgeons, the Norman Rowe Oration and the Stanford Cade gold medal. In 2004 he was awarded an honorary Doctorate degree from the University of Athens. He has served as Vice Dean in the Faculty of Clinical Dentistry at King's College School of Medicine and Dentistry, Clinical Director of the Dental Care Group at King's College Hospital NHS Trust and a Deputy Head Clinician Guy's, King's and St. Thomas' Cancer Center, Head and Neck Group. He has also served as Lead Clinician for Cancer Services at King's College Hospital NHS Trust. He has been an examiner in many Universities in England and abroad and in both the Royal College of Surgeons of England and Edinburgh of which he has served as Chairman of the Specialty Advisory Board in Oral and Maxillofacial Surgery. He has chaired the Intercollegiate Board of Oral and Maxillofacial Surgery. He has served two periods as an elected member of the Board of the Faculty of dental Surgery of the Royal College of Surgeons of England and has served as Vice-Dean of the Faculty. He has been elected President of the British Association of Oral and Maxillofacial Surgeons, the British Association of Head and Neck Oncologists, the section of Odontology of the Royal Society of Medicine and the Institute of Maxillofacial Prosthetists and Technologists. In 2002 he was elected to the Council of the Royal College of Surgeons of England.

Professor Jean-Louis Lefebvre, MD, PhD Professor of Otolaryngology, Head and Neck Surgery. University of Lille Deputy Director and Head of the Department of Otolaryngology, Head and Neck Surgery. Centre Oscar Lambret, Lille, France Jean-Louis Lefebvre, MD, Professor of ENT and Head and Neck Surgery, was born on March 4, 1947 in France. He trained at Lille University (1963-1970) and in the ENT-HNS service of the University Hospital (1970-1974). He upheld in 1974 his thesis on "Supracricoid Laryngectomies". He got a position of senior resident both in the ENT-HNS service and in the Anatomy and Organogenesis Laboratory (1974-1976). In 1976, he joined the Centre Oscar Lambret, the Northern France Comprehensive Cancer Center~ and became Chief of the Department in 1994. He took the position of Deputy Director of the Center (1996-2001) and was elected as the President of its Medical Commission in 2003. He chaired the EORTC HNC Group (1989-1998) and was member of the EORTC Board (1997-1999). He has been appointed as the Secretary General of the International Federation of Head and Neck Oncology Societies ( 2 0 0 3 ) and is chairing the Founding Board of the European Head and Neck Society (2003). He is a member of 22 HN societies and is involved in 15 scientific journals. He got in 1995 the Special Recognition Award of the SHNS. He gave the Myers International Lecture at the AAO-HNS (1996) and the Hayes Martin Lecture at the AHNS (1999).

Scientific Committee

13

Professor Lefebvre has published 291 papers, abstracts and chapters, directed 59 theses in medicine, presented 142 oral presentations and gave 105 invited lectures throughout the world mainly on the topics of larynx surgery, organ preservation and clinical research.

Professor Eugene N. Myers, MD Professor and Eye & Ear Foundation Chair of Otolaryngology University of Pittsburgh School of Medicine, Professor of Oral and Maxillofacial Surgery University of Pittsburgh School of Dental Medicine, Pittsburgh USA Professor Eugene Myers graduated from the Temple University School of Medicine in Philadelphia, Pennsylvania. He did his residency training in ENT at the Boston Massachusetts Eye and Ear Infirmary of Harvard Medical School where he also did an NIH special fellowship. He did an additional one year fellowship in Head and Neck Surgery with Dr. John Conley in New York City. He then moved to Pittsburgh were he was appointed Professor and Chairman of the Department of Otolaryngology at the University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania from 1972 to date. From 1975 to 1982 he was Professor of Clinical Oncology in the Department of Oral Pathology at the University of Pittsburgh School of Dental Medicine and since 1982 has held an appointment as Professor of Oral and Maxillofacial Surgery at the same institution. Professor Myers holds active and honorary membership in numerous scientific societies in the USA and abroad. He has been honored with several distinctions from professional ENT societies including a Presidential Citation from the American Head and Neck Society and the American Academy of Otolaryngology Head and Neck Surgery, the Daniel C. Baker Jr. Lecture of the American Laryngological Association, a Faculty Honoree of the University of Pittsburgh Honors Convocation, and a Distinguished Service Award from the American Academy of Otolaryngology Head and Neck Surgery. Professor Myers' own clinical interest in otolaryngology has been largely associated with the management of tumors of the head and neck. He has written more than 260 articles in peer-reviewed journals and has published several books, the most notable of which is Cancer of the Head and Neck together with Dr. James Y. Suen. Professor Myers is Past President of the American Board of Otolaryngology, the American Academy of Otolaryngology-Head and Neck Surgery, the American Laryngological Association, the American Head and Neck Society, and the Pan American Association of Otorhinolaryngology-Head and Neck Surgery. Professor Myers served as Coordinator for International Affairs of the American Academy of Otolaryngolog~Head and Neck Surgery Foundation from 1997 to 2003 and is currently International Editor of Otolao'ngology Head and Neck Surgery. Dr. Myers is also Principal Investigator of the Oral Cancer Center of Discovery funded by the National Institute of Dental and Craniofacial Research. Professor Myers has shared his professional life in clinical practice, teaching and research. Among his teaching achievements one can state an endless number of lectures and congress participations in numerous national and international meetings as well as lectures in several Universities and academic departments worldwide. He is a member of many editorial boards including the Laryngoscope, Head and Neck, Otolaryngology Head and Neck Surgery~ European Archives of Oto-Rhin~Laryngology~ Oncology, Auris Nasus Larynx, Archives of Otolaryngology Head and Neck Surgery and many more. Professor Myers' clinical, teaching~ research and scientific achievements rank him among the leading influential figures in the field of Otorhinolaryngology Head and Neck Surgery worldwide.

14

Scientific Committee

Professor Hiroyasu Noma, DDS, PhD Professor and Head, First Department of Oral and Maxillofacial Surgery, Tokyo Dental College and Vice Dean, Tokyo Dental College, Tokyo, Japan Professor Hiroyasu Noma graduated in Dentistry from Tokyo Dental College in 1962 and in 1966 received his PhD from the Graduate School of the same University. He finished his residency in Oral and Maxillofacial Surgery at Tokyo Dental College and in 1968 he was appointed Instructor in Oral and Maxillofacial Surgery. He rose through all academic ranks from Instructor to Associate Professor and in 1981 was appointed Professor and Chairman of the Oral and Maxillofacial Surgery in Tokyo Dental College. Until 2001 he was also the Director of Chiba Hospital of Tokyo Dental College and from June 2001 is the Vice Dean of the same institution. Professor Noma has a long list of academic and educational activities with numerous participations as an invited speaker in national and international Congresses including several conferences of the International Association of Oral and Maxillofacial Surgery, the Korean Society of Oral and Maxillofacial Surgery and the International Congress on Oral Cancer. Professor Noma is a member in numerous professional societies and associations including the Tokyo Dental College Society, Japanese Society of Oral and Maxillofacial Surgery, Japan Society for Head and Neck Cancer, Japan Society of Oral Tumor, Japanese Society for Jaw Deformities, Japanese Cancer Research, International Association of Oral and Maxillofacial Surgery, Asian Association of Oral and Maxillofacial Surgeons. He is the current President of the Asian Association of Oral and Maxillofacial Surgeons. He has published extensively in the national and international literature with more than 100 papers in peer-reviewed Journals. His scientific interests include reconstructive microsurgery of the maxillofacial region, clinical and experimental work on innervation of free flaps, biological research of oral carcinogenesis and genomic instability of oral cancer. Professor Noma is a leader in both clinical practice and research of Oral Cancer in Japan.

Professor Poul-Erik Petersen, DDS, MSe, PhD Chief Oral Health Programme, Non Communicable Disease Prevention and Health Promotion, World Health Organization, Geneva, Switzerland On 2 April 2002, Dr. Petersen was nominated Chief of the Oral Health Programme at the World Health Organization in Geneva. Prior to this date, Dr. Petersen was Professor in Community Dentistry at the University of Copenhagen. He has an academic background encompassing dentistry, public health and sociology, combined with broad international experience. Dr. Petersen has worked in community oral health research, enhancement of public health in universities worldwide, health systems development as well as in planning and implementation of community health projects in an extensive number of industrialised countries, countries with economies in transition and in developing countries.

Scientific Committee

15

Dr. Petersen worked in the WHO Regional Office for Europe as a consultant for several years, as a Director for the WHO Collaborating Centre for Community Oral Health Programmes and Research, and worked closely with numerous WHO Collaborating Centres in the field of oral health. He has assisted ministries of health, health authorities and health care planners throughout the world. In addition to Denmark, Dr. Petersen has studied in the USA and the UK. He was elected Dean of the School of Dentistry at the University of Copenhagen, and was also Vice-Director of the School of Public Health at the University of Copenhagen. He has an extensive list of scientific publications within epidemiology, health sociology, health systems research, disease prevention and health promotion, and international health. Within WHO Headquarters the Oral Health Programme is part of the Department of Chronic Diseases and Health Promotion, this emphasizes the links between oral health and general chronic disease prevention. Within the department, oral health will link with several of its activities, such as integrated NCD prevention networks, health promotion, nutrition, school health and healthy ageing.

Marco Piemonte, MD J Head of the Department of Otorhinolaryngology, Ospedale Santa Mafia della Misericordia Udine Italy, President 11 ~h International Congress on Oral ' Cancer 2006 Marco Piemonte graduated in medicine from the University of Milan, Italy. He specialized in Otorhinolaryngology - Head and Neck Surgery and Pathology from the University of Milan and in Audiology from the University of Trieste, Italy. He served as a Medical Officer (Captain) in the Italian Army Medical Service. He joined the Department of ENT Surgery Ospedale Santa Maria della Misericordia Udine Italy in 1997 and promoted from Assistant to Head of the unit. He has been Chairman of the Scientific Committee of this Hospital and responsible for technical and scientific updating of the hospital staff. Dr. Piemonte is a Fellow of the Italian ENT Society, the Italian Society of Pediatriac Otorhinolaryngology and the Italian Society of Surgical Oncology. He was a National Secretary of the Italian ENT Society from 1992 to 2001 and he continues to serve as a Consultant of the Council. His main clinical and research interests are in the treatment of head and neck cancer, thyroid and parathyroid pathology, laser surgery, otomicrosurgery and functional pathology of the upper aerodigestive system. He is the editor-in-chief of the official Journal of the Italian ENT Association, Acta Otorhinolaryngologica Italica. He has published a large number of papers in national and international peer-reviewed journals and has presented a large number of papers in hospital and academic departments and in national and international congresses.

Alexander D. Rapidis, MD, DDS, PhD Consultant and Head, Department of Maxillofacial Surgery, Greek Anticancer Institute, Saint Savvas Hospital, Athens Assistant Professor in Maxillofacial Surgery, University of Athens, Athens, Greece Hon. Senior Lecturer in Maxillofacial Surgery, Eastman Dental Institute, University College London, England Alexander D. Rapidis graduated in Dentistry and Medicine from the University of Athens and holds a PhD degree in Oral Medicine and Pathology. He was trained in Oral and Maxillofacial Surgery at the University of London and was a Hon. Lecturer in Oral and Maxillofacial Surgery in King's College

1~

Scientific Committee

Hospital Medical School. After his return to Greece, he was a Senior Registrar in Maxillofacial Surgery in the Athens Accident Hospital and the Laiko General University Hospital. Since 1990 he is Consultant and Head of the Department of Maxillofacial Surgery of the Greek Anticancer Institute "Saint Savvas Hospital" in Athens. In 2000 he was elected Assistant Professor of Oral and Maxillofacial Surgery in the University of Athens and in 2004 Hon. Senior Lecturer in Maxillofacial Surgery at Eastman Dental Institute, University College London, England. Dr. Rapidis is a Fellow of the European Boards of Oro-Maxillofacial Surgery UMS, member of the National Council of Research and Technology of the Greek Ministry of Development, Chairman of the Surgical Division of Saint Savvas Hospital and member of the Greek Examining Boards for the specialty of Oral and Maxillofacial Surgery. During the last five years he founded along with the Department of Plastic and Reconstructive Surgery the first unit of reconstructive microsurgery of the maxillofacial region. He is the author of more than 400 scientific works, 180 of which are publications in national and international medical journals. He has delivered a number of lectures, seminars and round table presentations in many University Departments and Hospitals in Greece and abroad.

Simon Rogers, BDS, MBChB (Hons), FSD, RCS (Eng), FRCS (Eng), FRCS (Max), MD Consultant Maxillofacial Surgeon, University Hospital Aintree, Liverpool UK Honorary Reader University of Liverpool In January 1999 Simon was appointed Consultant Maxillofacial Surgeon at the University Hospital Aintree and Honorary Reader, University of Liverpool. He is part of the multidisciplinary head and neck team and specialises in oral and oropharyngeal cancer and microvascular free tissue reconstruction. He has an interest is in health related quality of life (HRQOL) following oral cancer. He was awarded a Hunterian Professorship from the Royal College of Surgeons of England in 2002 for his research into the relationship between function and quality of life following primary surgery for oral and oropharyngeal cancer. He has several ongoing HRQOL studies, has published widely on this topic, and has been invited to speaker at many national and international scientific meeting. In 2003 he was invited to join the National Cancer Research Network (NCRN) Head and Neck cancer Clinical Studies Group. He has organised several courses, notably an International HRQOL workshop hosted at Liverpool, the most recent held in October 2004.

Professor Nabil Samman, FRCS, FDSRCS Professor of Oral and Maxillofacial Surgery, University of Hong Kong Director of Postgraduate Studies and Director of the Cleft Lip and Palate Centre, University of Hong Kong, China Professor Nabil Samman qualified in Medicine from London, UK and in Dentistry from Sydney, Australia. He is a surgical fellow of the Royal College of Surgeons of Edinburgh, and a Dental fellow of the Royal College of Surgeons of England. He is also a fellow of the College of Surgeons of Hong Kong and the Hong Kong Academy of Medicine.

Scientific Committee

17

He is chairman of the clinical pathology section of the International Journal of Oral and Maxillofacial Surgery, the Editor-in-Chief of the Asian Journal of Oral and Maxillofacial Surgery, Chairman of the Education Committee of the International Association of Oral and Maxillofacial Surgeons, President-Elect of the Asian Association of Oral and Maxillofacial Surgeons and President of the Hong Kong Association of Oral and Maxillofacial Surgeons. He is Director of the Cleft Lip and Palate Centre at the University of Hong Kong, Director of Postgraduate Studies and Professor in Oral and Maxillofacial Surgery at the University of Hong Kong. Professor Samman has published over 85 articles and 130 abstracts in the scientific literature. His main clinical interest is cleft surgery and oral cancer surgery.

Dr. Dhananjaya Saranath, MSc, PhD Deputy Director of Research, Jaslok Hospital and Research Centre, Mumbai, India, and Head of the Department of Molecular Medicine and Biology~ Jaslok Hospital and Research Centre, Mumbai, India Dr. Sananath an elected Fellow of the Maharashtra Academy of Sciences, India, is Deputy Director of Research, Jaslok Hospital and Research Centre, Mumbai, India, and Head of the Department of Molecular Medicine and Biology, Jaslok Hospital and Research Centre, Mumbai, India. Prior to her assignment at Jaslok Hospital, she was Head of the Laboratory of Cancer Genes, Cancer Research Institute, Tata Memorial Centre, Mumbai. She has been associated with the University of Bombay and Maharaja Sayajirao University of Baroda as a faculty member. The current research focus of Dr. Saranath at Jaslok Hospital and Research Centre in Oral Cancers is towards understanding the molecular pathology of the cancer, with emphasis on unraveling the molecular basis of Oral Cancer using state of art technologies such as microarray systems, tissue array systems and Single Nucleotide Polymorphisms. She aims to move in the direction of understanding the biological behavior of the cancer with clinical applications in defining diagnostic/prognostic/therapeutic response molecular markers. Her work on Molecular basis of Oral Cancer has been supported by national and international funding agencies and led to several awards including the prestigious Sandoz Oration Award of Indian Council of Medical Research, 1991; and Prof. Rudolf Fries Indo-German Award, at the Second International Congress on Oral Cancer. She has several publications in peer-reviewed national and international journals, is a member of the editorial board of prestigious scientific journals and reviewer in Indian government scientific funding agencies. She has also established a tissue/cell/DNA/RNA/Protein bank from cancer patients, primarily oral cancers and healthy tissues. She is the current President of the Indian association for Cancer Research.

James J. Seiubba, DMD, PhD Professor of Otolaryngology, Head and Neck Surgery, Pathology and Dermatology, The Johns Hopkins School of Medicine, Baltimore, Maryland Professor of Oral Biology and Pathology, School of Dental Medicine, S.U.N.Y., Stony Brook, New York Director of Dental and Oral Medicine, The Johns Hopkins Medical Center, Baltimore, Maryland, USA Professor Sciubba graduated in Dentistry from Fairleigh Dickinson University, School of Dentistry and did his PhD in Pathology at the University of illinois, Medical Center. He stayed at the University of

18

Scientific Committee

Illinois, College of Dentistry as an Instructor in Oral Pathology and Oral Biology and as an Assistant Professor in Clinical Oral Pathology before moving to the State University of New York at Stony Brook School of Dental Medicine. From September 1975 to 1984 he was Assistant Professor in Oral Biology and Pathology, Associate Professor in Oral Pathology and from 1974 to date is Professor of Oral Biology and Pathology at the same institution. From 1999 to date Dr. Sciubba is Professor of Otolaryngology, Head and Neck Surgery, Pathology and Dermatology at The Johns Hopkins School of Medicine, Baltimore, Maryland. Professor Sciubba has an active membership in various professional Societies in the USA and abroad and he serves in many professional national committees including the Oral Health Education Foundation, the American Dental Association, Council on Scientific Affaires, the Medical Advisory Board of Cancer Care and the Medical Advisory Board of the International Pemphigus Foundation. He is a past President of the American Academy of Oral Pathology and the Medical Board, Long Island Jewish Medical Center. He has been honored with numerous awards including the Teacher of the Year Award from the School of Dental Medicine, State University of New York at Stow Brook, and the Alumni Achievement Award from the Fairleigh Dickinson University. He is a fellow of the American and the International College of Dentists, and was honored with the Outstanding Service Award from Cancercare-United Way. Professor Sciubba serves in numerous editorial boards being the Oral Pathology Section Editor in the Journal of Hospital Dental Practice, Assistant Editor in the Journal of Oral Pathology, Editor in the Oral Pathology Section of Oral Surgery Oral Medicine Oral Pathology, Associate Editor in the Journal of Oral Pathology and Medicine and member of the Editorial Board of Oral Oncology. Professor Sciubba has published extensively in the national and the international literature with more than 140 papers and 40 structured abstracts in peer-reviewed Journals. He has written 7 books and contributed chapters in another 18 books. He has delivered a great number of lectures in Hospitals, Academic Departments and Universities in the USA and abroad. Professor Sciubba is a leading figure in the field of Oral and Maxillofacial Pathology and in the research of Oral Cancer.

Professor Crispian Scully CBE, MD, PhD, MDS, MRCS, FDSRCS, FDSRCPS, FFDRCSI, FDSRCSE, FRCPath, FMedSci Dean and Director of Studies and Research, Eastman Dental Institute; Professor of Oral Medicine, Pathology and Microbiology, University of London; Professor of Special Needs Dentistry, UCL Crispian Scully qualified in dentistry at the University of London in 1968 (honours), in Biochemistry in 1971 (first class honours) and in Medicine in 1974 (honours), before undertaking research funded by the Medical Research Council. His Doctor of Philosophy, in Pathology, was awarded in 1979 and he was appointed Lecturer and then Senior Lecturer in Oral Medicine and Immunology at the University of Glasgow, obtaining the Fellowship in Dental Surgery (Glasgow) in 1979. In 1982 he was appointed Chair and Head of Department of Oral Medicine, Surgery and Pathology at the University of Bristol. He was Dean from 1985 to 1990. He gained his Membership in Pathology (1983), Doctorate in Medicine (1987) and Mastership in Dental Surgery (1988) on the basis of research publications, the Fellowship in Oral Medicine (Ireland) by examination in 1989, the Fellowship in Dental Surgery (England) and the Fellowship of the Royal College of Pathologists in 1992, the Fellowship in Dental Surgery (Edinburgh) and the Fellowship of the Academy of Medical Sciences in 1998. In 1993 he was appointed to the Chair in Stomatology at the University of Geneva but declined in favour of the Deanship in the University of London.

Scientific Committee

19

In 1994 he was appointed Dean and Director of Studies and Research and specialist in Oral Medicine at the Eastman Dental Institute for Oral Health Care Sciences, and Professor of Oral Medicine, Pathology and Microbiology, of the University of London. He was re-appointed Dean in 1999, the Eastman having gained high ratings in Research and Teaching Assessments. In 2002 he accepted a further five year term as Dean of the Institute. He is Co-director of the World Health Organisation Collaborating Centre at the Eastman and Professor of Special Needs Dentistry. Professor Scully is also a member of the Court of Middlesex University, London. Professor Scully is Honorary Consultant at University College London Hospitals NHS Trust, at Great Ormond Street Hospital for Children NHS Trust, and at the European Institute for Oncology, Milan and has been Honorary Consultant at the John Radcliffe Hospital, Oxford, the Nuffield Orthopaedic Centre, Oxford, the Royal Free Hospital, London and at the Horizon Trust for Learning Disability, and Clinical Director of the Eastman Dental Hospital 1995-1996. Professor Scully is President of the European Association of Oral Medicine. His clinical expertise is mainly in Oral Medicine, especially oral problems in systemic diseases, ulceration, pain and white lesions, and in the oral health care of patients with Special Needs. He is a registered Specialist in Surgical Dentistry and in Oral Surgery. His main research interests are in relation to oral mucosal and salivary glands disease. Interests in oral cancer have been predominantly in the epidemiology and aetiopathogenesis of oral squamous carcinoma, and he was the first to show a rise in oral cancer in Britain, and the possible associations with viruses. He is also involved in health services research on aspects of viral hepatitis, HIV disease and other infections and immune defects, and has been instrumental in heightening awareness of the importance of infection control and occupational hazards. Professor Scully has published about 300 original research papers in these fields. He has published about 200 review articles, 100 chapters in books, 50 clinical papers and over 25 books. In 2000 he was honored with the title of Commander of the Order of the British Empire (CBE).

Professor Jatin P. Shah, MD, MS (Surg), FACS, Hon FRCS (Edin), Hon FRACS, Hon FDSRCS (Eng) Professor of Surgery, Weill Medical College, Cornell University, New York Chief, Head and Neck Service, and Professor WE Strong Chair in Head and Neck Oncology, Memorial Sloan-Kettering Cancer Center, New York, USA Dr. Jatin R Shah is Chief of the Head and Neck Service and Elliot W. Strong Chair in Head and Neck Oncology at Memorial Sloan-Kettering Cancer Center and he is Professor of Surgery at the Weill Medical College of Cornell University in New York, NY. He is a national and international leader in head and neck surgery, having served as President of the Society of Head and Neck Surgeons, The New York Cancer Society, The New York Head and Neck Society, and The North American Skull Base Society. He is currently the Director of the International Federation of Head and Neck Oncologic Societies. He is a member of 21 Editorial Boards of scientific journals and is an honorary member of Head and Neck Societies in Australia, New Zealand, Brazil, Korea, Belgium, South Africa, Philippines, Peru and India. Dr. Shah has received numerous awards from all parts of the world including an Honorary FRCS from the Royal College of Surgeons of Edinburgh, Honorary FDSRCS from the Royal College of Surgeons of England, and Honorary FRACS from the Royal Australasian College of Surgeons. His textbook of Head and Neck Surgery has won the First Prize from the Royal Society of Medicine as well as the First

20

Scientific Committee

Prize from the British Medical Association and the University of London as the best book in Head and Neck Surgery in the past five years. He has delivered over 40 named lectureships and keynote addresses at national and international conferences all over the world and has published six books, 48 chapters in various other textbooks and has published 238 peer-reviewed papers in scientific journals. He has delivered over 700 scientific lectures and presentations at various national and international meetings and conferences. Dr. Shah is a consummate surgeon, teacher, investigator, and leader in the field of head and neck surgery and oncology.

Professor Edward J. Shillitoe, BDS, PhD Professor and Chair Department of Microbiology and Immunology, Upstate Medical University, Syracuse, New York, USA Professor Shillitoe graduated with a degree in Dentistry from Guy's Hospital Dental School, University of London, England, in 1970. He performed graduate level research into viral immunity at the same institution, receiving the PhD degree in 1976. Following post-doctoral studies at Pennsylvania State University he held faculty appointments at the University of California, San Francisco, and the University of Texas, Houston. Since 1994 Dr. Shillitoe has been Professor and Chair of the Department of Microbiology and Immunology at Upstate Medical University, Syracuse, New York. Professor Shillitoe serves on the editorial boards of Oral Oncology~ Oral Diseases, and Biotechniques~ and was awarded the Experimental Pathology Research Award of the International Association for Dental Research in 2000. He has contributed more than 100 papers in peer-reviewed journals in the national and international literature. His main research interest over the last 10 years has been in the development of viruses for transfer of genes into oral cancers. Currently his laboratory is developing new mutants of herpes simplex virus for treatment of oral cancer. t

E. David Vaughan, FDSRCS, FRCS Senior Consultant Mercy Regional Centre for Maxillofacial Surgery David Vaughan is the creator of one of the largest maxillofacial units in the United Kingdom based in Liverpool. He is a Consultant for the past 23 years. His clinical activities are shared between the Regional

Scientific Committee

21

Maxillofacial Unit, University Hospital Aintree and the Mercy Regional Centre for Maxillofacial Surgery. His main interest is in the treatment of head and neck cancer. He is a pioneer of free tissue transfer fbr the reconstruction of maxillofacial area after ablative surgery. He was President of the British Association of Oral and Maxillofacial Surgeons in 2002 and he is the President Elect of the British Association of Head and Neck Oncologists for the years 2005-2007. He is an Honorary Fellow of several Associations including the American Association o f Oral and Maxillofacial Surgeons, the Greek Association of Oral and Maxillofacial Surgeons and the Israeli Association o f Oral and Maxillofacial Surgeons. He has been the President's Lecturer to the British and International Associations of Oral and Maxillofacial Surgeons. He is the author of over 80 papers in peer-reviewed Journals and has contributed Chapters in several books in Oral and Maxillofacial Surgery. He has given more than 100 lectures in Universities, Academic Departments and Hospitals in Europe, North America and the Far East.

Professor Saman Warnakulasuriya, BDS (Cey), FDSRCS (Eng & Edin), PhD (Glasg) Professor of Oral Medicine and Experimental Oral Pathology, University of London, Consultant in Oral Medicine, Guy's, King's & St. Thomas' Dental Institute, London, UK Professor Saman Warnakulasuriya qualified in Dentistry from the University of Ceylon in 1969 and was awarded the PhD by the University of Glasgow in 1976 for developing an in vitro model for the assessment of cell proliferation of human oral mucosa. He taught at the University of Peradeniya from 1976 to 1990 where he held the chair in Oral Medicine. He is a fellow in Dental Surgery of the Royal Colleges of Surgeons of England and Edinburgh. Professor Warnakulasuriya is currently Professor in Oral Medicine & Experimental Oral Pathology at King's College London. He is also the Head of the Department. He is an honorary consultant to King's College Hospital NHS Trust, Guy's and St. Thomas' NHS Trust and Northwick Park Hospitals NHS Trust. Professor Warnakulasuriya has published over 100 scientific peer-reviewed articles and lectured extensively on the subject of oral cancer and precancer from the levels of basic science to the management. He is an authority on global aspects of risk factors for oral cancer having conducted several field surveys both in Asia and Northern Africa. In Collaboration with the World Health Organization he conducted several innovative studies on screening for oral cancer using the primary health care model. He has assisted the IARC of the WHO to evaluate the carcinogenecity of areca nut. His consultancy skills include training and calibration of health care workers for the detection of oral cancer and precancer and in tobacco cessation. He is the Deputy Director of the WHO collaboration Centre for Oral Cancer and Precaner in the United Kingdom and Deputy Editor of Oral diseases. His current research interests are developing tumour and genetic markers for diagnosis and examining risks for oral cancer in different populations and the delivery of interventional programs directed at cessation of tobacco and areca nut usage. He was the principal investigator of a recently completed epidemiological study on oral cancer in young people in Southern England.

~_~_

Scientific Committee

Dr. Julia Woolga~; FRCPath, FDS, RCS (Eng), PhD Senior Lecturer and Honorary Consultant in Oral Pathology, University of Liverpool, Liverpool, UK Dr. Julia Woolgar, FRCPath, FDS RCS Eng, PhD, has been Senior Lecturer/Honorary Consukant in Oral Pathology at the University of Liverpool since 1994. She is the author of over 70 articles, with the majority of recent ones concerning oral cancer. She co-authors the Royal College of Pathologist's Standard an. Minimum Dataset for Histopathology Reports on Head and Neck Carcinomas and Salitmry Neoplasms" (1998, 2004). Histopathological studies on the local and regional lymphatic spread of oral cancer and their prognostic importance earned her The International Association of Oral & Maxillofacial Surgeons Prize for The Best Published Article in the Year 1997 and the Royal College of Surgeons of England John Tomes Prize Medal in 2002. In addition to her research achievements, she was Chairperson of the Pathology Sub-committee of the Head & Neck Group of the European Organization for Research and Treatment of Cancer (EORTC) from 2000 to 2003. Since 1996, she has played a key role in the development of Quality Assurance Schemes for histopathologists and has been the Organiser of the UK National Head and Neck Histopathology External Quality Assurance Scheme since its introduction in 2000. Her Editorial Board experience includes Oral Oncology (2001-2), The Asian Journal of Oral and MaxilloJ~tcial Surgely (since 2001) and The International Journal of Oral & MaxilloJ~tcial Surgery (since 2002).